Search
for
Sort by
Research 121–150 of 1000+
- How does covid-19 affect the skin?
- SUMMARIES OF PAPERS
- Immunoregulatory mechanisms and stress hormones in psoriasis (part 1)
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Nilontinib induced keratosis pilaris atrophicans
- Scleromyxedema with neurologic involvement: Therapy with intravenous immunoglobulin
- Abstracts from the 2025 WDS Forum
- Eczémas de contact atypiques ou sévères à l’huile essentielle de cannelle
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Nutritional Clinical Studies in Dermatology
- Medications
- Dermatología en la Práctica Médica General Vol. 13
- Herbal Therapy in Dermatology
- Cutaneous reactions to recombinant cytokine therapy
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata
- Psychoactive drugs and skin
- Herbal Treatment for Dermatologic Disorders
- Dermatologic therapy: December 1987 to December 1988
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Prurigo pigmentosa: A multi-institutional retrospective study
- Cutaneous Manifestations of COVID-19
- Netherton Syndrome With Trichorrhexis Invaginata “Bamboo Hair” Under Dermoscopy: Case Images
- Viva questions from the IJDVL
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- 1,314
- The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5‐Independent Manner
- The JAK/STAT signaling pathway: from bench to clinic